Accelerating therapies for rare neuromuscular disorders through European collaborations
January 29, 2026
January 29, 2026
LONDON, England, Jan. 29 -- The University College London posted the following news:
* * *
Accelerating therapies for rare neuromuscular disorders through European collaborations
*
UCL has joined a pioneering European consortium working to discover new treatments for rare neuromuscular disorders (NMDs).
The DREAMS consortium brings together leading institutions from across the continent to develop data-driven, patient-derived model . . .
* * *
Accelerating therapies for rare neuromuscular disorders through European collaborations
*
UCL has joined a pioneering European consortium working to discover new treatments for rare neuromuscular disorders (NMDs).
The DREAMS consortium brings together leading institutions from across the continent to develop data-driven, patient-derived model . . .
